A Pilot and Feasibility Study to Evaluate the Effectiveness of Tofacitinib Add-On Therapy to Remdesivir in Severely Ill COVID-19 Patients.

Dargahi-Malamir M, Hosseinzadeh M, Khedri R, Hosseininejad H, Behmanesh B, Hatami A, Oskouei SY, Mehraban Z, Kouti W, Pouladzadeh M

Open source

DOI: 10.26574/maedica.2024.19.2.322
Published: 2024 Jun
Container: Maedica
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.26574/maedica.2024.19.2.322,
  title = {A Pilot and Feasibility Study to Evaluate the Effectiveness of Tofacitinib Add-On Therapy to Remdesivir in Severely Ill COVID-19 Patients.},
  author = {Dargahi-Malamir M and Hosseinzadeh M and Khedri R and Hosseininejad H and Behmanesh B and Hatami A and Oskouei SY and Mehraban Z and Kouti W and Pouladzadeh M},
  year = {2024},
  journal = {Maedica},
  doi = {10.26574/maedica.2024.19.2.322},
  url = {https://doi.org/10.26574/maedica.2024.19.2.322}
}

RIS

TY  - JOUR
TI  - A Pilot and Feasibility Study to Evaluate the Effectiveness of Tofacitinib Add-On Therapy to Remdesivir in Severely Ill COVID-19 Patients.
AU  - Dargahi-Malamir M
AU  - Hosseinzadeh M
AU  - Khedri R
AU  - Hosseininejad H
AU  - Behmanesh B
AU  - Hatami A
AU  - Oskouei SY
AU  - Mehraban Z
AU  - Kouti W
AU  - Pouladzadeh M
PY  - 2024
JO  - Maedica
DO  - 10.26574/maedica.2024.19.2.322
UR  - https://doi.org/10.26574/maedica.2024.19.2.322
ER  -

APA

M, D., M, H., R, K., H, H., B, B., A, H., SY, O., Z, M., W, K., & M, P. (2024). A Pilot and Feasibility Study to Evaluate the Effectiveness of Tofacitinib Add-On Therapy to Remdesivir in Severely Ill COVID-19 Patients.. Maedica. https://doi.org/10.26574/maedica.2024.19.2.322

Source records

pubmed · retrieved 2026-09-26T07:27:11.155Z